MAPT and Alzheimer disease: iPSC-derived organoids carrying familial AD mutations (APP, PSEN1, PSEN2) exhibit accelerated Aβ42/40 ratios, enhanced plaque formation, increased tau misfolding, and mitochondrial dysfunction, mirroring early pathogenic cascades observed in human AD brains [91].